The Assessment of Convalescent Plasma Efficacy against COVID-19

Antibody-based therapy for infectious diseases predates modern antibiotics and, in the absence of other therapeutic options, was deployed early in the SARS-CoV-2 pandemic through COVID-19 convalescent plasma (CCP) administration. Although most studies have demonstrated signals of efficacy for CCP, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadevall, Arturo, Grossman, Brenda J., Henderson, Jeffrey P., Joyner, Michael J., Shoham, Shmuel, Pirofski, Liise-anne, Paneth, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747676/
https://www.ncbi.nlm.nih.gov/pubmed/33363284
http://dx.doi.org/10.1016/j.medj.2020.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747676/
https://www.ncbi.nlm.nih.gov/pubmed/33363284
http://dx.doi.org/10.1016/j.medj.2020.11.002

Ejemplares similares